Activation of simulator of interferon genes (STING), which induces the production of proinflammatory factors and immune effector cell activation, is considered a promising strategy for enhanced anti-cancer intervention.
However, several obstacles prevent STING signalling in solid tumours, such as delivered molecules’ rapid degradation, restriction to tumour sites, insufficient intracellular concentrations, and low responsivity.
Well-designed, multifunctional nano-formulations have emerged as optimised platforms for STING activation.
Recently, a variety of nano-formulations have been developed and used in STING activation, thus facilitating immunotherapy in preclinical and clinical stages.
The authors of this article summarise recent advances in nanotechnology-based delivery, activation, and application strategies, which have advanced various aspects of immunotherapy.
Novel STING agonists and their mechanisms in STING-activation-mediated tumour interventions are highlighted, to provide a comprehensive overview and discuss future directions for boosting immunotherapy via STING regulation.
Article: Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
Source: Compuscript Ltd
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.